Article ID Journal Published Year Pages File Type
10910865 Lung Cancer 2015 37 Pages PDF
Abstract
Patritumab in combination with erlotinib was well tolerated and the efficacy of the combination was encouraging, especially in patients where prior gefitinib treatment failed.
Related Topics
Life Sciences Biochemistry, Genetics and Molecular Biology Cancer Research
Authors
, , , , , , , , , ,